Company VIA Pharmaceuticals, Inc. Other OTC
Equities
VIAP
US92554T1034
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
Small-molecule Drugs
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Sales per region
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
United States
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 70 | 01/04/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 70 | 01/04/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 2,000 | 0 | 0 | 100.00 % |
Stock B | 1 | 20,558,446 | 20,558,446 ( 100.00 %) | 0 |
Company contact information
VIA Pharmaceuticals, Inc.
750 Battery Street Suite 330
94111-9991, San Francisco
+
![address VIA Pharmaceuticals, Inc.(VIAP)](https://cdn.zonebourse.com/static/address/11277.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+38.36% | 52.73B | |
+38.99% | 39B | |
-8.63% | 38.52B | |
+25.46% | 30.38B | |
-11.17% | 26.39B | |
+11.44% | 26.08B | |
+45.09% | 14.15B | |
+32.93% | 12.6B | |
-5.30% | 11.51B |